CASE REPORT
Eosinophilic fasciitis and hypoalbuminaemia
Online publication date: 2012-06-27
Reumatologia 2012;50(3):255-260
KEYWORDS
ABSTRACT
Eosinophilic fasciitis is a rare disease of connective tissue of unknown etiology. It appears separately or in connection with other autoimmunological or oncological diseases. Sclerosis of subcutaneous tissue in some localized places is a specific symptom of eosinophilic fasciitis. There are no determined treatment standards of the disease so far, but the studies describing case reports indicate that eosinophilic fasciitis is a self-limited disease. In the current study a case with diagnosed eosinophilic fasciitis is presented and compared with other selected cases of that disease found in the available literature. Additionally the low level of albumins administrated was noted in the described case and attempts of explanation were undertaken. The treatment and its results are also presented (Tables I–III).
REFERENCES (24)
1.
Shulman LE. The eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan. Arthritis Rheum 1990; 33: 913-917.
2.
Szczeklik A. Choroby wewnętrzne. Stan wiedzy na rok 2011. Wydanie 3. Medycyna Praktyczna, Kraków 2011.
3.
Bobrowska-Snarska D, Ostanek L, Brzosko M. Eozynofilowe zapalenie powięzi. Opis 5 przypadków i przegląd literatury. Pol Arch Med Wew 2007; 117: 184-191.
4.
Wisłowska M, Rok M, Matuszyk M. Eozynofilowe zapalenie powięzi – opis przypadku. Reumatologia 2005; 43: 35-38.
5.
Bukiej A, Dropiński J, Dyduch G, Szczeklik A. Eosinophilic fasciitis successfully treated with cyclosporine. Clin Rheumatol 2005; 24: 634-636.
6.
Pupka A, Janczak D, Maj J i wsp. Eozynofilowe zapalenie powięzi u chorego na miażdżycę zarostową tętnic kończyn dolnych i tętniaka aorty brzusznej. Trudności terapeutyczne. Przegl Dermatol 2003; 3: 193-196.
7.
Różycka B, Szepietowski J, Szybejko-Machaj G i wsp. Eozynofilowe zapalenie powięzi u chorego na sarkoidozę płucną: trudności teraputyczne. Post Dermat Alerg 2001; 28: 242-246.
8.
Samborski W, Żaba R. Zastosowanie dożylnej pulsacyjnej terapii glikokortykosteroidami u chorego na eozynofilowe zapalenie powięzi. Dermatol Klin 2000; 2: 33-36.
9.
Puszczewicz M, Zimmerman-Górska I, Pietrzak-Kaczmarek H i wsp. Problemy diagnostyczne związane z eozynofilowym zapaleniem powięzi. Pol Arch Med Wew 2006; 116: 777-780.
10.
Małdykowa H, Jędryka-Góral A, Polowiec Z. Fasciitis eozynophilica w świetle obserwowanych przypadków. Reumatologia 1983; 21: 277-284.
11.
Bachmeyer C, Monge M, Dhote R, et al. Eosinophilic fasciitis following idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia and Hashimoto’s disease. Dermatology 1999; 199: 282-282.
12.
Fleming CJ, Clarke P, Kemmett D. Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporin. Br J Dermatol 1997; 136: 297-299.
13.
Varga J, Griffin R, Newman JH, Jimenez SA. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use. J Rheumatol 1991; 18: 259-263.
14.
Khanna D, Verity A, Grossman JM. Eosinophilic fasciitis with multiple myeloma: a new haematological association. Ann Rheum Dis 2002; 61: 1111-1112.
15.
Bonnotte B, Chauffert B, Caillot D, et al. Successful treatment with antithymocyte globulin and cyclosporin A of a severe aplastic anaemia associated with an eosinophilic fasciitis. Br J Rheumatol 1998; 37: 1358-1359.
16.
Abeles M, Belin DC, Zurier RB. Eosinophilic fasciitis: a clinicopathologic study. Arch Intern Med 1979; 139: 586-588.
17.
Wollheim FA, Lindstrom CG, Eiken O. Eosinophilic fasciitis complicated by carpal tunnel syndrome. J Rheumatol 1981; 8: 856-860.
18.
Lakhanpal S, Ginsburg WW, Michet CJ. Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 1988; 17: 221-231.
19.
Solomon G, Barland P, Rifkin H. Eosinophilic fasciitis responsive to cimetidine. Ann Intern Med 1982; 97: 547-549.
20.
Romano C, Rubegni P, De Aloe G, et al. Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis. J Eur Acad Dermatol Venereol 2003; 7: 10-13.
21.
Dembińska-Kieć A, Naskalski JW. Diagnostyka laboratoryjna z elementami biochemii klinicznej. Elsevier Urban & Partner, Wrocław 2010. .
22.
Dejmková H, Hulínska D, Tegzová D, et al. Seronegative Lyme arthritis caused by Borrelia garinii. Clin Rheumatol 2002; 21: 330-334.
23.
Tylewska-Wierzbanowska S, Chmielewski T. Limiation of serologic testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods. Wien Klin Wochenschr 2002; 114: 601-605.
24.
Deroń E, Kieć-Świerczyńska M. Rola Helicobacter Pylori w powstawaniu chorób skóry. Medycyna Pracy 2002; 53: 333-337.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
RELATED ARTICLE
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
